Table 4.
Status of patients who reported spectacle use postoperatively.
| Patient/implantation | Age (years) | Spectacle use preoperatively | Spectacle use postoperatively | VA of unoperated eye | VA of operated eye(s) |
|---|---|---|---|---|---|
| 1/unilateral | 50 | Progressive glasses | Progressive glasses | Habitual VA 20/20; CDVA 20/20 (MRSE-3.38 D) | UDVA 20/20; UIVA 20/50; UNVA 20/25 |
|
| |||||
| 2/unilateral | 49 | Progressive glasses | Glasses for intermediate | Habitual VA 20/20; CDVA 20/15 (MRSE-0.13 D) | UDVA 20/20; UIVA 20/80; UNVA 20/25 |
|
| |||||
| 3/bilateral | 50 | No glasses | Glasses for intermediate | — | RE UDVA 20/20; UIVA 20/50; UNVA 20/25 LE UDVA 20/15; UIVA 20/100; UNVA 20/25 |
|
| |||||
| 4/bilateral | 54 | Glasses for distance | Glasses for near | — | RE UDVA 20/15; UIVA 20/50; UNVA 20/25 LE UDVA 20/20; UIVA 20/25; UNVA 20/25 |
|
| |||||
| 5/bilateral | 57 | No glasses | Glasses for intermediate and near | — | RE UDVA 20/20; UIVA 20/20; 20/25 LE UDVA 20/30; UIVA 20/25; UNVA 20/32 |
D = Diopters; LE = left eye; MRSE = manifest refraction spherical equivalent; UDVA = uncorrected distance visual acuity; UIVA = uncorrected intermediate visual acuity; UNVA = uncorrected near visual acuity; RE = right eye; VA = visual acuity.